================================================================================

                UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    Form 8-K

                                 CURRENT REPORT
     PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

                                 January 4, 2005
                Date of Report (Date of Earliest Event Reported):

                                  ABAXIS, Inc.
             (Exact name of registrant as specified in its charter)

          California                      000-19720              77-0213001
(State or other Jurisdiction of   (Commission File Number)    (I.R.S. Employer)
        Incorporation)                                       Identification No.)

                                3240 Whipple Road
                              Union City, CA 94587
          (Address of principal executive offices, including zip code)

                                 (510) 675-6500
              (Registrant's telephone number, including area code)

     Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[ ]  Written communications pursuant to Rule 425 under the Securities Act
     (17 CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act
     (17 CFR 240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c))

================================================================================



ITEM 8.01 OTHER EVENTS.

On January 4, 2005, Abaxis, Inc., announced today changes in its domestic sales
and marketing structure and management leadership team with the goal of
providing increased management focus in both the veterinarian and medical
markets and to accelerate growth. A copy of the press release is attached hereto
as Exhibit 99.1.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

        (c)      EXHIBITS.

        The following exhibit is furnished with this report on Form 8-K:

        Exhibit No.       Description
        -----------       -----------------------------------
        99.1              Press release dated January 4, 2005

                                        2


                                   SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Date:  January 4, 2005

                                                Abaxis, Inc.

                                                By: /s/ Alberto Santa Ines
                                                    ---------------------------
                                                    Alberto Santa Ines
                                                    Vice President, Finance and
                                                    Chief Financial Officer
                                                    Chief Financial Officer

                                        3